BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical & Diagnostic

Telix Advances Development of Glioblastoma Therapy Program

TLX101 (4-L-[131I] iodo-phenylalanine, or 131I-IPA) is one of the Company's lead therapeutic clinical programs and has been granted orphan drug design...

March 23, 2022 | News

Gene Solutions Makes Earlier Detection of Cancer A Possibility of the Future

Globally, cancer causes one in six deaths with more than 21 million people developing annually. 70% of cancers in patients are detected at late stages in w...

March 16, 2022 | News

Baxter to tackle the growing burden of kidney disease in Asia Pacific

Baxter Asia Pacific (Baxter), a global leader in dialysis care, has launched the Know Your Score campaign across Asia Pacific (APAC) on...

March 10, 2022 | News

Arctoris and Evariste Technologies form a Joint Venture to Identify Novel Small Molecule cMET Inhibitors for Non-Small Cell Lung Cancer

Arctoris, a tech-enabled biopharma company, and Evariste Technologies, an AI-drug discovery company, today announced they have formed a joint venture to id...

March 08, 2022 | News

Malaysian-Made ProDetect(R) Rapid Test-Kit Scores 100% Accuracy in International Assessment

As the Omicron variant takes hold in Malaysia, the availability of high accuracy Antigen Test Kits is increasingly vital in the drive to identify infe...

March 02, 2022 | News

India based Amrita University launch wearable device for home monitoring of glucose and BP

Amrita University has developed a device for home-monitoring of glucose and blood pressure. Amrita Spandanam, as the device is called, will be sold online ...

March 02, 2022 | News

GSK has launched the inaugural Shingles Awareness Week

GSK has launched the inaugural Shingles Awareness Week to educate the general public about shingles in collaboration with the International Federation on...

February 28, 2022 | News

RosVivo signed MTA for diabetes treatment with Eli Lilly and Company

RosVivo Therapeutics, Inc. (hereinafter referred to as "RosVivo") announced that it has signed a Material Transfer Agreement (MTA) with one of the largest ...

February 23, 2022 | News

First Japanese Institution to Utilize SOPHiA GENETICS' Myeloid Plus Solution

Hiroshima University is home to one of the largest university research institutes in the field of radiation biomedical science in Japan. With NGS...

February 23, 2022 | News

Kato Wins FDA Approval for Human Studies of Drug for Retinal Disorders

Kato Pharmaceuticals, a privately-held clinical stage biopharmaceutical company, today announced that the FDA has approved the company's investigational ne...

February 21, 2022 | News

Analysis of DNA reveals weapons used by our immune cells to fight Tuberculosis

The team used high-throughput genomic technologies to learn how the DNA packaging inblood cells changes when a person has active TB, a bacterial disease th...

February 17, 2022 | News

First Proton Therapy Treatment Delivered in Southeast Asia

The Varian ProBeam uses sophisticated imaging to see, adapt, and deliver treatment to the designated site, using a powerful particle accelerator called the...

February 09, 2022 | News

Singapore (HSA) approval marks the first in a series of expected approvals of Trodelvy in Asia

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative ph...

February 07, 2022 | News

LISCure Biosciences Announces Research Collaboration with The Scripps Research Institute for Immuno-Oncology

Scripps Research is the top nonprofit scientific institute in the US for producing high-quality research based on discoveries published in leading scientif...

February 04, 2022 | News

Stay Connected